German Dortmund Tobacco and Smoking Accessories Exhibition 2022

Sep.12.2022
German Dortmund Tobacco and Smoking Accessories Exhibition 2022
The Dortmund International Tobacco Products and Smoking Accessories Exhibition is the world's largest tobacco trade show.

The 2019 Dortmund International Tobacco Products and Smoking Accessories Exhibition (referred to as the "Dortmund Tobacco Fair") boasted 40,000 square meters of exhibit space, 13,800 professional attendees and over 600 exhibitors from 59 countries, including top companies such as Philip Morris International, British American Tobacco, Imperial Tobacco and Swedish Match. More than 90% of participants reported having a say in their company's purchasing decisions, and all of the companies' products sold out during the event, leading to exceptional amounts of orders. This fair is the largest tobacco products and accessories trade show in the world and has been successfully held for 43 years since its establishment in 1978.


From September 15 to 17, 2022, the three-day German Dortmund Tobacco Exhibition returns, providing exhibitors and professional visitors with one of the largest tobacco trade show platforms in the world.


Dortmund Tobacco Expo Logo in Germany


Despite the inconvenience caused by the pandemic, the Electronic Cigarette Committee of the China Electronic Commerce Association (ECCC) remains committed to providing its member companies with high-quality overseas services.


The Electronic Cigarette Industry Committee (ECCC) is partnering with 2FIRSTS2firsts.com to send an "ECCC International Exhibition Team" to attend the tobacco exhibition in Dortmund, Germany. The team will provide one-stop exhibition services to Chinese e-cigarette companies interested in participating. The "ECCC International Exhibition Team" is a professional, efficient, and versatile unit that aims to solve the concerns of its member enterprises. Companies will no longer need to send additional personnel overseas, as they can now achieve a "cloud exhibition" domestically.


The head of international business for the "ECCC International Exhibition Group" is Jason, who is a public relations manager for 2FIRSTS. He will lead his team to Germany to explain their exhibition products to event attendees, facilitate negotiations and partnerships for member companies, and showcase a positive image of Chinese electronic cigarette businesses. The goal is to generate a strong presence for Chinese electronic cigarette companies at this exhibition.


With the strong global influence of the ECCC and the comprehensive industry reporting capabilities of 2FIRSTS2firsts.com, the "ECCC International Exhibition Team" will provide real-time product showcases and explanations for participating companies, fully showcasing their strength and competitiveness. It will also offer video connections and coverage for the Chinese and global atomization industry, displaying the development trends and future prospects of the industry.


The China Electronic Cigarette Chamber of Commerce (ECCC), a highly influential and authoritative organization in the domestic atomization industry, will spare no effort in opening up a window for its member units to keep abreast of the world and the times. It will assist Chinese electronic cigarette companies in making more contributions to earning foreign exchange through exports.


To learn more about exhibition information, please contact Chen Yang from the Electronic Cigarette Committee Secretariat at 15218746134.


This article contains excerpts or reproductions of content sourced from third-party information. The copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any entity or individual who wishes to reprint should contact the author and refrain from direct reproduction.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello Warns on Illicit Cigarettes as Legal Tobacco Sales Halve Over Decade
New Zealand Associate Health Minister Casey Costello said legal tobacco sales in the country have fallen by more than half over the past decade, with sales declining more than 20% in 2025 compared with the previous year. She warned that the decline may not fully reflect lower smoking rates, as increased availability of illicit cigarettes could also be contributing. The government said it would continue strengthening tobacco and vape retail enforcement while monitoring the impact of illicit tobacco on public health and tax revenue.
Aug.26
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
Germany collected €9.789 billion in total tobacco tax revenue from January through August 2026, down 10.8% from a year earlier, according to the Federal Ministry of Finance. Germany's tobacco tax base covers not only cigarettes and fine-cut tobacco but also heated tobacco and vaping liquids taxed as tobacco substitutes. The German Association of the Tobacco Industry and Novel Products, or BVTE, citing federal statistical data, said tax-paid cigarette volume fell 12.6% to 40.6 billion sticks. BVTE is using the latest figures to argue against further tax increases planned from 2027 through 2030, while Germany's parliament is scheduled to hold a first reading of the bill on September 24.
Sep.23
Major U.S.  Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
Major U.S. Vape Distributor Demand Vape Pays at Least $300,000 for White House Lobbying Amid Enforcement Pressure
New York vape distributor Ecto World, which operates as Demand Vape, hired political consultant Roger Stone to lobby the Executive Office of the President on regulation of vaping and related products while facing state enforcement and multiple lawsuits. Public lobbying disclosures show that Ecto World paid at least $300,000 for the work through June 30, 2026. Separately, New York State announced in March that more than 28,500 pounds of vaping products tied to the company had been seized, while New York City and the state have pursued legal or enforcement actions. Public records do not show that the lobbying directly changed any specific regulatory or enforcement outcome.
Sep.08
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24